{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-041716","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2026-09-08T13:00:42+00:00","discovered_at":"2026-09-08T13:02:00.294273+00:00","generated_at":"2026-09-08T13:02:08.099903+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"HCW Biologics signs exclusive distribution deal with Akron Biotech for HCW11-006 reagent","bullets":["Exclusive worldwide distribution (ex-China) of HCW11-006 as CAR-T manufacturing reagent; 5-year term.","Advance payments: $200k at closing, $100k within 30 days of Supply Agreement, $100k on each of 1st and 2nd anniversaries.","Closing by Nov 30, 2026, subject to due diligence and product testing; Supply Agreement to be negotiated within 60 days of closing.","HCW11-006 is a multi-cytokine fusion molecule; preclinical data show CAR-Ts made with it have enhanced anti-tumor and antiviral activity.","Akron is a leading supplier of ancillary materials for cell/gene therapy; deal marks first commercialization of HCW's TRBC platform product."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-041716","json":"https://secwatch.observer/filing/0001493152-26-041716.json","markdown":"https://secwatch.observer/filing/0001493152-26-041716.md","text":"https://secwatch.observer/filing/0001493152-26-041716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226041716/0001493152-26-041716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000149315226041716/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-08T13:02:08.099903+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}